Novel transcatheter closure of an iatrogenic perimembranous ventricular septal defect

Catheter Cardiovasc Interv. 2015 Jan 1;85(1):161-5. doi: 10.1002/ccd.25651. Epub 2014 Sep 13.

Abstract

Iatrogenic membranous ventricular septal defects (VSD) are rare complications of cardiothoracic surgery, most commonly seen as a complication of aortic valve replacements. An iatrogenic VSD can lead to right sided heart failure, systemic hypoxia, and arrhythmias, and closure is often necessary. Given the increased mortality associated with repeat surgical procedures, percutaneous transcatheter closure of these iatrogenic VSDs has increasingly become the preferred choice of therapy. We describe the first case of iatrogenic membranous VSD in the setting of mitral valve replacement and tricuspid valve repair, using the newly approved Amplatzer Duct Occluder II Device from an entirely retrograde approach. © 2014 Wiley Periodicals, Inc.

Keywords: VSD; closure; interventional devices/innovation; structural heart disease intervention.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Cardiac Catheterization* / instrumentation
  • Echocardiography, Doppler, Color
  • Heart Injuries / diagnosis
  • Heart Injuries / etiology
  • Heart Injuries / therapy*
  • Heart Valve Prosthesis Implantation / adverse effects*
  • Humans
  • Iatrogenic Disease*
  • Male
  • Prosthesis Design
  • Septal Occluder Device
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Ventricular Septum / injuries*